治疗乙肝新药物的研究进展与评价  

Evaluation and development of new drugs against Hepatitis B Virus

作　　者：翁水旺[1] 沈诗景[1] 

机构地区：[1]福建省药品检验所,福州350001

出　　处：《海峡药学》2010年第12期101-103,共3页Strait Pharmaceutical Journal

摘　　要：了解治疗乙肝新药物的研究进展。方法采用国内外文献综述方法。结果新药拉米夫定、阿德福韦和恩替卡韦有抑制乙肝病毒作用。结论它们的联合应用有很强的抗乙肝病毒效果。OBJECTIVE To investigate Development of new drugs against Hepatitis B Virus.METHODS Literature both home and abroad was reviewed.RESULTS There were inhibits HBV in the new drugs of lamivudine,adefovir and enticavir.CONCLUSION Combination of the new drugs has sound effects against Hepatitis B Virus.

关 键 词：新药 拉米夫定、阿德福韦和恩替卡韦 抗乙肝病毒 

分 类 号：R969.4[医药卫生—药理学]